Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Testicular disposition of clofarabine in rats is dependent on equilibrative nucleoside transporters.

Authors: Miller, Siennah R; Jilek, Joseph L; McGrath, Meghan E; Hau, Raymond K; Jennings, Erin Q; Galligan, James J; Wright, Stephen H; Cherrington, Nathan J

Published In Pharmacol Res Perspect, (2021 Aug)

Abstract: Acute lymphoblastic leukemia (ALL) is the most common cancer in children and adolescents. Although the 5-year survival rate is high, some patients respond poorly to chemotherapy or have recurrence in locations such as the testis. The blood-testis barrier (BTB) can prevent complete eradication by limiting chemotherapeutic access and lead to testicular relapse unless a chemotherapeutic is a substrate of drug transporters present at this barrier. Equilibrative nucleoside transporter (ENT) 1 and ENT2 facilitate the movement of substrates across the BTB. Clofarabine is a nucleoside analog used to treat relapsed or refractory ALL. This study investigated the role of ENTs in the testicular disposition of clofarabine. Pharmacological inhibition of the ENTs by 6-nitrobenzylthioinosine (NBMPR) was used to determine ENT contribution to clofarabine transport in primary rat Sertoli cells, in human Sertoli cells, and across the rat BTB. The presence of NBMPR decreased clofarabine uptake by 40% in primary rat Sertoli cells (p = .0329) and by 53% in a human Sertoli cell line (p = .0899). Rats treated with 10 mg/kg intraperitoneal (IP) injection of the NBMPR prodrug, 6-nitrobenzylthioinosine 5'-monophosphate (NBMPR-P), or vehicle, followed by an intravenous (IV) bolus 10 mg/kg dose of clofarabine, showed a trend toward a lower testis concentration of clofarabine than vehicle (1.81 ± 0.59 vs. 2.65 ± 0.92 ng/mg tissue; p = .1160). This suggests that ENTs could be important for clofarabine disposition. Clofarabine may be capable of crossing the human BTB, and its potential use as a first-line treatment to avoid testicular relapse should be considered.

PubMed ID: 34288585 Exiting the NIEHS site

MeSH Terms: Animals; Antimetabolites, Antineoplastic/pharmacokinetics*; Biological Transport; Cells, Cultured; Clofarabine/pharmacokinetics*; Equilibrative Nucleoside Transporter 1/antagonists & inhibitors; Equilibrative Nucleoside Transporter 1/metabolism*; Equilibrative-Nucleoside Transporter 2/antagonists & inhibitors; Equilibrative-Nucleoside Transporter 2/metabolism*; Humans; Lamivudine/blood; Lamivudine/pharmacokinetics; Lamivudine/pharmacology; Male; Rats; Rats, Sprague-Dawley; Telomerase/genetics; Testis/metabolism*; Thioinosine/analogs & derivatives; Thioinosine/blood; Thioinosine/pharmacokinetics; Thioinosine/pharmacology; Thionucleotides/blood; Thionucleotides/pharmacokinetics; Thionucleotides/pharmacology

Back
to Top